Moreover, it was also reported that activation of AMPK by metformin could also be used as a potential strategy for prevention of cancer metastasis through disruption of E-cadherin-mediated cell–cell adhesion by blocking the expression of tumor invasion-related signaling molecules, such as TGF-β and Vimentin [34, 35]. This evidence concerns the gene TGFB1 and neoplasm.